← Back to Search

Poly-phenylpropanoid-polysaccharide complex

capsule for Allergic Rhinitis (PCE Trial)

N/A
Waitlist Available
Led By Dennis Ledford, M.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks

Summary

This trial tests a pine cone extract on adults with year-round nasal allergies. The extract aims to reduce substances in the body that cause allergy symptoms. Participants will take the extract daily for a period of time to see if it helps with their allergies.

Eligible Conditions
  • Allergic Rhinitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Objective ( total serum IgE)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: capsuleActive Control1 Intervention
patinets receiveing pine cone extract tablets
Group II: placebo capsulePlacebo Group1 Intervention
patinets receiving placebo

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
426 Previous Clinical Trials
192,033 Total Patients Enrolled
Dennis Ledford, M.D.Principal InvestigatorDivision of Allergy and Immunology, USF

Media Library

Pine Cone Extract (Poly-phenylpropanoid-polysaccharide complex) Clinical Trial Eligibility Overview. Trial Name: NCT04024033 — N/A
Allergic Rhinitis Research Study Groups: placebo capsule, capsule
Allergic Rhinitis Clinical Trial 2023: Pine Cone Extract Highlights & Side Effects. Trial Name: NCT04024033 — N/A
Pine Cone Extract (Poly-phenylpropanoid-polysaccharide complex) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04024033 — N/A
~2 spots leftby Nov 2025